Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats

European Journal of Clinical Investigation

Volumn 40, Issue 2, 2010, Pages 164-171

  Hsieh, Po Shiuan ^a,b   Lu, K C ^c   Chiang, C F ^a   Chen, C H ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Adipose tissue; Cyclooxygenase 2; High fat diet; Inflammation; Obesity

Indexed keywords

CELECOXIB; CHLORDANE; CYCLOOXYGENASE 2 INHIBITOR; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NIMESULIDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; ENERGY; EPIDIDYMIS FAT; GENE EXPRESSION; HEMODYNAMIC PARAMETERS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID DIET; MALE; METABOLIC PARAMETERS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SUBCUTANEOUS FAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD GLUCOSE; BLOOD PRESSURE; CHEMOKINE CCL2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; FATS; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN; INTRA-ABDOMINAL FAT; OBESITY; POLYMERASE CHAIN REACTION; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SUBCUTANEOUS FAT, ABDOMINAL; SULFONAMIDES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75149164466     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02239.x     Document Type: Article

References (23)

1. Flier JS, Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004 116 : 337 350.
2. Wellen KE, Hotamisligil GS, Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005 115 : 1111 1119.
3. Wellen KE, Hotamisligil GS, Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue [comment]. J Clin Invest 2003 112 : 1785 1788.
4. Kershaw EE, Flier JS, Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004 89 : 2548 2556.
5. Sartipy P, Loskutoff DJ, Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003 100 : 7265 7270.
6. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001 175 : 81 92.
7. Murdolo G, Hammarstedt A, Sandqvist M, Schmelz M, Herder C, Smith U et al. Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin. J Clin Endocrinol Metab 2007 92 : 2688 2695.
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. et al. Obesity is associated with macrophage accumulation in adipose tissue [see comment]. J Clin Invest 2003 112 : 1796 1808.
9. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006 281 : 26602 26614.
10. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006 116 : 1494 1505.
11. Hsieh P-S, Jin J-S, Chiang C-F, Chan P-C, Chen C-H, Shih K-C. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity 2009 17 : 1150 1157.
12. Hsieh PS, Tsai HC, Kuo CH, Chan JY, Shyu JF, Cheng WT et al. Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats. Eur J Clin Invest 2008 38 : 812 819.
13. Yoshino T, Kimoto A, Kobayashi S, Noguchi M, Fukunaga M, Hayashi A et al. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. Arzneimittelforschung 2005 55 : 394 402. (Pubitemid 41021083)
14. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp [see comment]. Diabetes Care 1999 22 : 1462 1470.
15. Foley JE, Chen YD, Lardinois CK, Hollenbeck CB, Liu GC, Reaven GM. Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniques. Horm Metab Res 1985 17 : 406 409.
16. Hsieh PS, Tai YH, Hsieh P-S, Tai Y-H. Aqueous extract of Monascus purpureus M9011 prevents and reverses fructose-induced hypertension in rats. J Agric Food Chem 2003 51 : 3945 3950.
17. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance [see comment]. J Clin Invest 2003 112 : 1821 1830.
18. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995 96 : 88 98.
19. Albu JB, Kovera AJ, Johnson JA. Fat distribution and health in obesity. Ann N Y Acad Sci 2000 904 : 491 501.
20. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, Gagua M et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 2008 28 : 1654 1659.
21. Kawano J, Arora R, Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr 2009 4 : 44 9.
22. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999 96 : 272 277.
23. Widlansky ME, Price DT, Gokce N, Eberhardt RT, Duffy SJ, Holbrook M et al. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension. Hypertension 2003 42 : 310 315.